大象传媒

Published

Husky Buys Advanced Multishot Technology from MGS

Move expands Husky’s offering of fully integrated, multimaterial solutions, improving manufacturing efficiency and performance.  

Share

Husky Technologies has purchased a secondary injection unit and rotary platen technologies from MGS Healthcare Manufacturing (MGS), a global provider of health care manufacturing solutions. In a release, Husky says the acquisition further strengthens its position as a leading provider of integrated multimaterial solutions across key industries, including medical, packaging and consumer electronics.

This move enables precision secondary injection units and rotary platens to be integrated with Husky’s industry-leading Altanium mold controller technology. Integrating these advanced multishot technologies enhances Husky’s ability to provide comprehensive, high-performance, turnkey solutions tailored to the production of multimaterial and multicolor applications.

These technologies also enable Husky to expand its offering of fully integrated, multimaterial solutions, improving manufacturing efficiency and performance, the company says. What’s more, it creates new opportunities for growth in the packaging, medical, personal and home care markets, enabling producers to benefit from a more complete range of innovative, high-performing solutions, according to Husky.

Husky Buys MGS Multi-Shot Technology
Source: Husky

“This acquisition reinforces our commitment to innovation and excellence,” notes Robert Domodossola, Husky’s president of systems and tooling. “By bringing these complementary technologies into our portfolio, we are enhancing our ability to serve customers with integrated, high-performance solutions that drive efficiency and growth.”

Adds Shawn Krenke, chief technology officer of MGS: “MGS is pleased to announce the divestiture of its Multishot product line to Husky. As a global leader in injection molding technology and a key strategic supplier to MGS, Husky is the ideal organization to take over and continue advancement of the Multishot product line. This divestiture allows MGS to concentrate on being a world-class contract development and manufacturing partner to our health care customers and we are dedicated to working closely with Husky to ensure a seamless transition and integration for all future and existing customers.”

Related Content